R SE, Fidan DD, Frankish R, Maxwell L: Rofecoxib for osteoarthritis. Cochrane Database Syst Rev 2005(1). Art No.: CD005115. DOI: ten.1002/14651858.CD005115. 12. Berenbaum F, Grifka J, Brown JP, Zacher J, Moore A, Krammer G, Dutta D, Sloan VS: Efficacy of lumiracoxib in osteoarthritis: a evaluation of nine studies. J Int Med Res 2005, 33:21?1. 13. Lange B, Kuperwasser B, Okamoto A, Steup A, H fel T, Ashworth J, Etropolski M: Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis discomfort and low back pain. Adv Ther 2010, 27:381?99. 14. Zhang W, Jones A, Doherty M: Does paracetamol (acetaminophen) decrease the discomfort of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 2004, 63:901?07. 15. Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G: Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006(1). Art No.: CD004257. DOI: 10.1002/14651858.CD004257.pub2. 16. Porzio F: Meta-analysis of 3 double-blind comparative trials with sustained-release etodolac in the therapy of osteoarthritis from the knee. Rheumatol Int 1993, 13:19?4. 17. Chen Y-F, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS: Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic assessment and financial evaluation. Well being Technol Assess 2008, 12:1?78. iii. 18. Avouac J, Gossec L, Dougados M: Efficacy and security of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthr Cartil 2007, 15:957?65. 19. Lee C, Straus WL, Balshaw R, Barlas S, Vogel S, Schnitzer TJ: A comparison of the efficacy and security of nonsteroidal antiinflammatory agents versus acetaminophen inside the treatment of osteoarthritis: a meta-analysis. Arthritis Care Res 2004, 51:746?54. 20. Riedemann PJ, Bersinic S, Cuddy LJ, Torrance GW, Tugwell PX: A study to identify the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in individuals with osteoarthritis: a meta-analysis. J Rheumatol 2095, 1993:20. 21. Towheed TE, Hochberg MC: A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis on the hip.4CzIPN Order J Rheumatol 1997, 24:349?57.Price of Amino-PEG3-C2-Amine 22.PMID:23789847 Furlan A, Sandoval J, Mailis-Gagnon A, Tunks E: Opioids for chronic noncancer pain: a meta-analysis of effectiveness and unwanted effects. CMAJ 2006, 174:1589?594. 23. Mayyas F, Fayers P, Kaasa S, Dale O: A systematic overview of oxymorphone within the management of chronic pain. J Pain Symptom Handle 2010, 39:296?08. 24. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM: Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010(1). Art No.: CD006605. DOI: 10.1002/ 14651858.CD006605.pub2. 25. Papaleontiou M, Henderson CR Jr, Turner BJ, Moore AA, Olkhovskaya Y, Amanfo L, Reid MC: Outcomes associated with opioid use inside the treatment of chronic noncancer pain in older adults: a systematic critique and meta-analysis. J Am Geriatr Soc 2010, 58:1353?369. 26. Chappell AS, Desaiah D, Liu-Seifert H, Zhang S, Skljarevski V, Belenkov Y, Brown JP: A double-blind, randomized, placebo-controlled study on the efficacy and safety of duloxetine for the remedy of chronic discomfort due to osteoarthritis in the knee. Pain Pract 2011, 11:33?1. 27. Chappell A, Ossanna M, Liu-Seifert H, Iyengar S, Skljarevski V, Li L, Bennett R, Collins H: Duloxet.